Laura Wollborn

Laura Wollborn

Auto-generated profile, based on publicly available information

Laura Wollborn

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Cancer Prevention Research
Verified
Journal Article
Closed access
SAStephanie Alimena
Stephanie Alimena
BSBriana Joy K. Stephenson
Briana Joy K. Stephenson
JWJames W. Webber
James W. Webber
LWLaura Wollborn
Laura Wollborn
CSChad B. Sussman
Chad B. Sussman
KEKevin M Elias
Kevin M Elias
Serum miRNAs are promising biomarkers for several clinical conditions, including ovarian cancer. To inform equitable implementation of these tests, we investigated the effects of race, ethnicity, and socioeconomic status on serum miRNA profiles. Serum samples from a large institutional biobank were analyzed using a custom panel of 179 miRNA species highly expressed in human serum, measured using the Abcam Fireplex assay via flow cytometry. Data were log-transformed prior to analysis. Differences in miRNA by race and ethnicity were assessed using logistic regression. Pairwise t tests analyzed racial and ethnic differences among eight miRNAs previously associated with ovarian cancer risk. Pearson correlations determined the relationship between mean miRNA expression and the social deprivation index (SDI) for Massachusetts residents. Of 1,586 patients (76.9% white, non-Hispanic), compared with white, non-Hispanic patients, those from other racial and ethnic groups were younger (41.9 years ± 13.2 vs. 51.3 ± 15.1, P < 0.01) and had fewer comorbidities (3.5 comorbidities ± 2.7 vs. 4.6 ± 2.8, P < 0.01). On logistic regression, miRNAs predicted race and ethnicity at an AUC of 0.69 (95% confidence interval, 0.66–0.72), which remained consistent when stratified by most comorbidities. Among eight miRNAs previously associated with ovarian cancer risk, seven significantly varied by race and ethnicity (all P < 0.01). There were no significant differences in SDI for any of these eight miRNAs. miRNA expression is significantly influenced by race and ethnicity, which remained consistent after controlling for confounders. Understanding baseline differences in biomarker test characteristics prior to clinical implementation is essential to ensure instruments perform comparably across diverse populations. Prevention Relevance: This study aimed to understand factors affecting miRNA expression, to ensure we create equitable screening tests for ovarian cancer that perform well in diverse populations. The goal is to ensure that we are detecting ovarian cancer cases earlier (secondary prevention) in women of all races, ethnic backgrounds, and socioeconomic means.

14 June 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
LWLaura Wollborn
Laura Wollborn
JWJames W. Webber
James W. Webber
SAStephanie Alimena
Stephanie Alimena
SMSudhanshu Mishra
Sudhanshu Mishra
CSChad B. Sussman
Chad B. Sussman
KEKevin M Elias
Kevin M Elias
Background: Serum miRNAs are potential biomarkers for ovarian cancer; however, many factors may influence miRNA expression. To understand potential confounders in miRNA analysis, we examined how sociodemographic factors and comorbidities, including known ovarian cancer risk factors, influence serum miRNA levels in women without ovarian cancer. Methods: Data from 1,576 women from the Mass General Brigham Biobank collected between 2012 and 2019, excluding subjects previously or subsequently diagnosed with ovarian cancer, were examined. Using a focused panel of 179 miRNA probes optimized for serum profiling, miRNA expression was measured by flow cytometry using the Abcam FirePlex assay and correlated with subjects’ electronic medical records. Results: The study population broadly reflected the New England population. The median age of subjects was 49 years, 34% were current or prior smokers, 33% were obese (body mass index > 30 kg/m2), 49% were postmenopausal, and 11% had undergone prior bilateral oophorectomy. Significant differences in miRNA expression were observed among ovarian risk factors such as age, obesity, menopause, BRCA1 or BRCA2 germline mutations, or existence of breast cancer in family history. Additionally, miRNA expression was significantly altered by prior bilateral oophorectomy, hypertension, and hypercholesterolemia. Other variables, such as smoking; parity; age at menarche; hormonal replacement therapy; oral contraception; breast, endometrial, or colon cancer; and diabetes, were not associated with significant changes in the panel when corrected for multiple testing. Conclusions: Serum miRNA expression patterns are significantly affected by patient demographics, exposure history, and medical comorbidities. Impact: Understanding confounders in serum miRNA expression is important for refining clinical assays for cancer screening.

2 April 2024
Verified
Other
Open access
PDF file
SAStephanie Alimena
Stephanie Alimena
BSBriana Joy K. Stephenson
Briana Joy K. Stephenson
JWJames W. Webber
James W. Webber
LWLaura Wollborn
Laura Wollborn
CSChad B. Sussman
Chad B. Sussman
KEKevin M Elias
Kevin M Elias
Supplemental Table 3 shows the ratio of non-white mean fluorescence units (MFI) to white MFI for the eight miRNA associated with ovarian cancer risk. MFI for non-white patients were on average higher for these race-associated miRNA compared to white patients (significance denoted with an asterisk).

2 April 2024
Verified
Other
Open access
PDF file
SAStephanie Alimena
Stephanie Alimena
BSBriana Joy K. Stephenson
Briana Joy K. Stephenson
JWJames W. Webber
James W. Webber
LWLaura Wollborn
Laura Wollborn
CSChad B. Sussman
Chad B. Sussman
KEKevin M Elias
Kevin M Elias
Supplemental Table 3 shows the ratio of non-white mean fluorescence units (MFI) to white MFI for the eight miRNA associated with ovarian cancer risk. MFI for non-white patients were on average higher for these race-associated miRNA compared to white patients (significance denoted with an asterisk).

2 April 2024
Verified
Other
Open access
PDF file
SAStephanie Alimena
Stephanie Alimena
BSBriana Joy K. Stephenson
Briana Joy K. Stephenson
JWJames W. Webber
James W. Webber
LWLaura Wollborn
Laura Wollborn
CSChad B. Sussman
Chad B. Sussman
KEKevin M Elias
Kevin M Elias
Supplemental Table 2: Correlation between all tested socioeconomic indices and miRNA values for eight miRNA previously associated with ovarian cancer risk, among Massachusetts residents. We confined this analysis to Massachusetts residents given there were a minority of non-Massachusetts residents in the cohort, and zip code was needed to perform the correlations with various socioeconomic indices.

3 March 2025
Verified
Other
Open access
LWLaura Wollborn
Laura Wollborn
JWJames W. Webber
James W. Webber
SAStephanie Alimena
Stephanie Alimena
SMSudhanshu Mishra
Sudhanshu Mishra
CSChad B. Sussman
Chad B. Sussman
KEKevin M Elias
Kevin M Elias
Log2 expression values of miRNAs used for statistical tests.